Literature DB >> 10988105

FEV(6) is an acceptable surrogate for FVC in the spirometric diagnosis of airway obstruction and restriction.

M P Swanney1, R L Jensen, D A Crichton, L E Beckert, L A Cardno, R O Crapo.   

Abstract

We analyzed the FEV(1)/FEV(6) and FEV(1)/FVC results of 502 consecutive patients in the spirometric diagnosis of airway obstruction. We also examined the agreement between FEV(6) and FVC in the spirometric diagnosis of restriction. Technically acceptable test results were obtained from 337 subjects (67%). The sensitivity of FEV(1)/FEV(6) for diagnosing airway obstruction as defined by FEV(1)/ FVC was 95.0%; the specificity was 97.4%. When interpretations differed, the measured values were all close to the lower limits of the reference ranges. When analysis included +/- 100-ml variability in FEV(1) and FEV(6), the sensitivity increased to 99.5% and the specificity to 100%. The reproducibility of FEV(6) was superior to that of FVC. These results suggest that FEV(6) is an accurate, reliable alternative to FVC for diagnosing airway obstruction and that FEV(6) is reasonably comparable to FVC for the spirometric diagnosis of restriction. FEV(6) is more reproducible and less physically demanding for patients.

Entities:  

Mesh:

Year:  2000        PMID: 10988105     DOI: 10.1164/ajrccm.162.3.9907115

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  35 in total

1.  Redefining spirometry hesitating start criteria based on the ratio of extrapolated volume to timed FEVs.

Authors:  Julie M McKibben; Roy T McKay; Andrew G Freeman; Linda S Levin; Susan M Pinney; Enas Alshaikh
Journal:  Chest       Date:  2010-11-24       Impact factor: 9.410

2.  Standardisation of lung function testing: helpful guidance from the ATS/ERS Task Force.

Authors:  G Laszlo
Journal:  Thorax       Date:  2006-09       Impact factor: 9.139

3.  Prediction of forced expiratory volume in pulmonary function test using radial basis neural networks and k-means clustering.

Authors:  Sujatha C Manoharan; Swaminathan Ramakrishnan
Journal:  J Med Syst       Date:  2009-10       Impact factor: 4.460

4.  FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices.

Authors:  Surya P Bhatt; Young-Il Kim; James M Wells; William C Bailey; Joe W Ramsdell; Marilyn G Foreman; Robert L Jensen; Douglas S Stinson; Carla G Wilson; David A Lynch; Barry J Make; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2014-03

5.  Re-Defining Lower Limit of Normal for FEV1/FEV6, FEV1/FVC, FEV3/FEV6 and FEV3/FVC to Improve Detection of Airway Obstruction.

Authors:  James E Hansen; Janos Porszasz; Richard Casaburi; William W Stringer
Journal:  Chronic Obstr Pulm Dis       Date:  2015-03-10

6.  Risk factors for COPD spirometrically defined from the lower limit of normal in the BOLD project.

Authors:  Richard Hooper; Peter Burney; William M Vollmer; Mary Ann McBurnie; Thorarinn Gislason; Wan C Tan; Anamika Jithoo; Ali Kocabas; Tobias Welte; A Sonia Buist
Journal:  Eur Respir J       Date:  2011-12-19       Impact factor: 16.671

7.  FEV(6) as screening tool in spirometric diagnosis of obstructive airway disease.

Authors:  P Adithya Malolan; Vishak Acharya; B Unnikrishnan
Journal:  Lung India       Date:  2010-04

8.  A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria.

Authors:  Asli Gorek Dilektasli; Janos Porszasz; Richard Casaburi; William W Stringer; Surya P Bhatt; Youngju Pak; Harry B Rossiter; George Washko; Peter J Castaldi; Raul San Jose Estepar; James E Hansen
Journal:  Chest       Date:  2016-07-22       Impact factor: 9.410

9.  Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.

Authors:  Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

10.  A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with chronic obstructive pulmonary disease.

Authors:  Charles K N Chan; François Maltais; Chris Sigouin; Jennifer M Haddon; Gordon T Ford
Journal:  Can Respir J       Date:  2007 Nov-Dec       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.